Labcorp Holdings, Inc. (LH)
363.30
-4.49
(-1.22%)
USD |
NYSE |
Nov 05, 16:00
363.24
-0.06
(-0.02%)
After-Hours: 20:00
Labcorp Holdings Cash from Investing (Quarterly) : -433.70M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -433.70M |
| June 30, 2026 | -366.20M |
| March 31, 2026 | -322.10M |
| December 31, 2025 | -389.90M |
| September 30, 2025 | -374.00M |
| June 30, 2025 | -94.10M |
| March 31, 2025 | -336.00M |
| December 31, 2024 | -209.60M |
| September 30, 2024 | -579.10M |
| June 30, 2024 | -185.00M |
| March 31, 2024 | -393.10M |
| December 31, 2023 | -330.60M |
| September 30, 2023 | -487.60M |
| June 30, 2023 | -253.60M |
| March 31, 2023 | -99.70M |
| December 31, 2022 | -273.30M |
| September 30, 2022 | -563.30M |
| June 30, 2022 | -242.50M |
| March 31, 2022 | -573.10M |
| December 31, 2021 | -254.50M |
| September 30, 2021 | -407.30M |
| June 30, 2021 | -90.40M |
| March 31, 2021 | -132.40M |
| December 31, 2020 | -128.00M |
| September 30, 2020 | -285.20M |
| Date | Value |
|---|---|
| June 30, 2020 | -123.40M |
| March 31, 2020 | -106.60M |
| December 31, 2019 | -152.10M |
| September 30, 2019 | -239.70M |
| June 30, 2019 | -750.80M |
| March 31, 2019 | -140.50M |
| December 31, 2018 | -146.90M |
| September 30, 2018 | 549.90M |
| June 30, 2018 | -122.00M |
| March 31, 2018 | -74.30M |
| December 31, 2017 | -178.30M |
| September 30, 2017 | -1.314B |
| June 30, 2017 | -491.40M |
| March 31, 2017 | -245.50M |
| December 31, 2016 | -219.60M |
| September 30, 2016 | -317.70M |
| June 30, 2016 | -106.80M |
| March 31, 2016 | -151.60M |
| December 31, 2015 | -128.60M |
| September 30, 2015 | -82.70M |
| June 30, 2015 | -132.30M |
| March 31, 2015 | -3.651B |
| December 31, 2014 | -147.30M |
| September 30, 2014 | -55.60M |
| June 30, 2014 | -39.10M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | -169.00M |
| OPKO Health, Inc. | 15.54M |
| Myriad Genetics, Inc. | -3.20M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | -11.85M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 563.80M |
| Cash from Financing (Quarterly) | -10.00M |
| Free Cash Flow | 1.287B |
| Free Cash Flow Per Share (Quarterly) | 5.052 |
| Free Cash Flow to Equity (Quarterly) | 402.40M |
| Free Cash Flow to Firm (Quarterly) | 459.61M |
| Free Cash Flow Yield | 4.30% |